In this free webinar, learn how advanced autoimmune testing supports diagnostic clarity in early or ambiguous clinical presentations. The featured speakers will review case-based evidence of how serological test results can inform long-term clinical decisions. The speakers will discuss how providers are using comprehensive serologic profiles to increase confidence in diagnosis and inform individualized patient care. Attendees will gain confidence in using innovative diagnostic tools along with routine autoimmune workups for better care.
TORONTO, July 29, 2025 /PRNewswire/ — The diagnostic process for patients with suspected autoimmune diseases is often long and uncertain, characterized by vague symptoms, overlapping clinical presentations and limitations in traditional serological testing. This complexity can delay accurate diagnosis and treatment, leading to disease progression and diminished quality of life. This webinar will explore how advanced serological testing methods like AVISE CTD are helping clinicians navigate this complexity by enhancing diagnostic precision for autoimmune diseases, including lupus and rheumatoid arthritis.
AVISE® tests provide a comprehensive serological profile by combining cell-bound complement activation products (CB-CAPs), high-quality systemic lupus erythematosus (SLE)-specific biomarkers, and a proprietary algorithm to support more confident and earlier diagnosis, enabling physicians to act decisively at a critical juncture in the patient’s journey. Through real-world case studies, this session will highlight how diagnostic clarity from enhanced testing approaches has informed provider decision-making, enabled appropriate therapeutic initiation, and ultimately led to improved patient outcomes.
Tailored for rheumatologists and healthcare professionals involved in autoimmune diseases, this webinar offers practical, evidence-based insights into the role of innovative diagnostics in daily clinical practice. Attendees will gain a deeper understanding of how leveraging advanced diagnostic tools, like AVISE CTD can enhance decision-making and improve the lives of patients affected by these complex and chronic conditions.
Register now to discover how advanced serological testing is revolutionizing the diagnosis and treatment of autoimmune diseases.
Join Dr. Alfred Kim, MD, PhD, Associate Professor, Medicine, Washington University School of Medicine; Dr. Priya Reddy, MD, Rheumatologist; and Dr. James Mossell, DO, FACR, Director of Rheumatology, Tift Regional Medical Center, for the live webinar on Wednesday, August 20, 2025, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Beyond Diagnosis: The Real-World Impact of AVISE Testing on Lupus, Rheumatoid Arthritis, and Autoimmune Disease Care.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/
View original content to download multimedia:https://www.prnewswire.com/news-releases/beyond-diagnosis-the-real-world-impact-of-avise-testing-on-lupus-rheumatoid-arthritis-and-autoimmune-disease-care-upcoming-webinar-hosted-by-xtalks-302515541.html
SOURCE Xtalks
